Such tests are increasingly moving beyond their origins in cutting-edge research and into the laboratory and diagnostic ...

A study published in November in the American Journal of Clinical Pathology that Emerson co-authored validated the analyzer against the Sysmex XN Automated Hematology System and found that CytoChip's ...

A major jump in modern medicine for Ohio State’s Wexner Medical Center has arrived. The hospital is among the first in the ...

Roche and Eli Lilly have started testing a blood test that could be used to diagnose Alzheimer’s before symptoms arise, providing an alternative to expensive brain scans and speeding up the ...

The Hematocrit Test Devices Market was valued at US$ 5.1 billion in 2022 and is estimated to grow at a CAGR of 3.4% from 2023 ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

Roche is in talks with the agency to determine which recommendations to implement, so it seems unlikely FDA will have to take the time-consuming r ...

Highly compact and cost-effective. Micro-sampling from whole blood (CBC : 30 µL - DIFF: 53 µL). Cytochemistry, Impedance (real cell volume measurement) & Optical (analysis of the internal ...

Merck's injected version of its blockbuster cancer drug Keytruda could face a potential patent challenge from biotech Halozyme Therapeutics , the Wall Street Journal reported on Wednesday, citing ...